RPS6 and glioblastoma: Western blot analysis revealed that stellettin B treatment dose-dependently downregulated Akt, mTOR, and ribosomal protein S6 phosphorylation in both the U87MG and GBM8401 glioblastoma cells within 24 h (Figure 3).